Olaparib for BRCA-mutated advanced ovarian cancer

被引：2
|
作者：
de Lartigue, Jane
机构：
来源：
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2015年 / 13卷 / 06期
关键词：
D O I：
10.12788/jcso.0138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：206 / 208
页数：3
相关论文
共 50 条
  • [21] Maintenance olaparib in Asian patients with germline BRCA-mutated metastatic pancreatic cancer
    Oh, Do-Youn
    Park, Joon Oh
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Arnold, Dirk
    Reinacker-Schick, Anke
    Tortora, Giampaolo
    Algul, Hana
    O'Reilly, Eileen M.
    McGuiness, David
    Liu, Yu-Zhen
    Cui, Karen
    Schlienger, Katia
    Locker, Gershon Y.
    Golan, Talia
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S319 - S319
  • [22] Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study
    Ales-Martinez, Jose E.
    Balmana, Judith
    Sanchez-Rovira, Pedro
    Bofill, Francisco Javier Salvador
    Garcia-Saenz, Jose Angel
    Pimentel, Isabel
    Murillo, Serafin Morales
    Fernandez, Adela
    Martinez, Ainhara Lahuerta
    Ferrer, Neus
    Zamora, Pilar
    Bermejo, Begona
    Diaz-Redondo, Tamara
    Lopez-Ceballos, Maria Helena
    Galan, Maria
    Malfettone, Andrea
    Calabuig, Laura
    Sampayo-Cordero, Miguel
    Perez-Garcia, Jose Manuel
    Cortes, Javier
    Llombart-Cussac, Antonio
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [23] FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
    Kim, Geoffrey
    Ison, Gwynn
    Mckee, Amy E.
    Zhang, Hui
    Tang, Shenghui
    Gwise, Thomas
    Sridhara, Rajeshwari
    Lee, Eunice
    Tzou, Abraham
    Philip, Reena
    Chiu, Haw-Jyh
    Ricks, Tiffany K.
    Palmby, Todd
    Russell, Anne Marie
    Ladouceur, Gaetan
    Pfuma, Elimika
    Li, Hongshan
    Zhao, Liang
    Liu, Qi
    Venugopal, Rajesh
    Ibrahim, Amna
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4257 - 4261
  • [24] Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer
    Nicoletto, Maria Ornella
    Baldoni, Alessandra
    Cavallin, Francesco
    Grego, Andrea
    Falci, Cristina
    Nardin, Margherita
    Mammano, Enzo
    Lai, Eleonora
    Torri, Valter
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [25] MAINTENANCE TREATMENT WITH OLAPARIB IN BRCA-MUTATED HIGH GRADE SEROUS OVARIAN CANCER (HGSOC): OUR EXPERIENCE IN A CASE REPORT
    Mainella, A.
    Giacomi, N.
    Marmissolle, F.
    Vigo, S.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Zapata Caamano, G.
    Dominguez, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1585 - 1585
  • [26] Are there clinical factors that can predict prolonged survival of patients receiving olaparib as maintenance therapy for BRCA-mutated ovarian cancer?
    Lieberman, Howard B.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 418 - 420
  • [27] BUDGET IMPACT ANALYSIS FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN COSTA RICA
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    Landaverde, D.
    Gonzalez, I
    [J]. VALUE IN HEALTH, 2018, 21 : S21 - S21
  • [28] Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
    Bourien, Heloise
    Lefevre, Leila Bengrine
    Mouret-Reynier, Marie-Ange
    Asselain, Bernard
    Lucas, Brigitte
    Gavoille, Celine
    Cornila, Corina
    Gavoille, Laurene
    Colomba, Emeline
    Patsouris, Anne
    Fabbro, Michel
    Chakiba, Camille
    Toussaint, Philippe
    Simon, Helene
    Berton, Dominique
    Garbay, Delphine
    Tixidre, Claire Garnier
    Coeffic, David
    Morvan, Aurelie
    Collard, Olivier
    Rouge, Thibault De La Motte
    [J]. ANTICANCER RESEARCH, 2023, 43 (02) : 653 - 662
  • [29] Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?
    Boulos, Mariana
    Moujaes, Elissar
    Nsouli, Ghazi
    Tfayli, Arafat
    Kourie, Hampig Raphael
    [J]. PHARMACOGENOMICS, 2022, 23 (08) : 487 - 492
  • [30] Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Wu, Bin
    Shi, Lizheng
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11): : 1528 - +
12345